Search
Now showing items 1-10 of 70
Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya.
(PLoS One, 2011)
BACKGROUND: There is increased risk of cardiovascular disease among HIV seropositive
individuals. The prevalence of HIV is highest in sub-Saharan Africa; however, HIV-related
cardiovascular risk research is largely derived ...
Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
(PLoS One, 2017)
BACKGROUND: Atrial fibrillation (AF) is a major contributor to the global cardiovascular
disease burden. The clinical profile and outcomes of AF patients with valvular heart
diseases in sub-Saharan Africa (SSA) have not ...
Simplified Predictive Instrument to Rule Out Acute Coronary Syndromes in a High-Risk Population.
(J Am Heart Assoc, 2015-12-14)
BACKGROUND: It is unclear whether diagnostic protocols based on cardiac markers to
identify low-risk chest pain patients suitable for early release from the emergency
department can be applied to patients older than 65 years ...
Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients.
(Ann Am Thorac Soc, 2016-03)
RATIONALE: Limitations in methods for the rapid diagnosis of hospital-acquired infections
often delay initiation of effective antimicrobial therapy. New diagnostic approaches
offer potential clinical and cost-related improvements ...
Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
(J Am Heart Assoc, 2015-05-21)
BACKGROUND: The characteristics of patients undergoing atrial fibrillation (AF) ablation
and subsequent outcomes in community practice are not well described. METHODS AND
RESULTS: Using the Outcomes Registry for Better Informed ...
Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.
(BMJ Open, 2015-05-06)
OBJECTIVES: Identification of patient subpopulations susceptible to develop myocardial
infarction (MI) or, conversely, those displaying either intrinsic cardioprotective
phenotypes or highly responsive to protective interventions ...
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
(J Cardiovasc Pharmacol, 2015-05)
Furosemide has historically been the primary loop diuretic in heart failure patients
despite data suggesting potential advantages with torsemide. We used the Duke Echocardiography
Lab Database to investigate patients admitted ...
Relationship of T2-Weighted MRI Myocardial Hyperintensity and the Ischemic Area-At-Risk.
(Circ Res, 2015-07-17)
RATIONALE: After acute myocardial infarction (MI), delineating the area-at-risk (AAR)
is crucial for measuring how much, if any, ischemic myocardium has been salvaged.
T2-weighted MRI is promoted as an excellent method to ...
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
(Circ Heart Fail, 2015-07)
BACKGROUND: Congestion is the most frequent cause for hospitalization in acute decompensated
heart failure. Although decongestion is a major goal of acute therapy, it is unclear
how the clinical components of congestion ...
Downstream coronary effects of drug-eluting stents.
(Am Heart J, 2011-10)
BACKGROUND: Antiproliferative agents used in drug-eluting stents (DES) attenuate atherosclerosis,
yet DES implantation has been linked to endothelial dysfunction. The downstream effects
of DES on new lesion formation have ...